InvestorsHub Logo
Followers 22
Posts 2743
Boards Moderated 1
Alias Born 03/06/2001

Re: MASTERTRADER post# 17013

Saturday, 02/25/2012 6:08:11 AM

Saturday, February 25, 2012 6:08:11 AM

Post# of 58396
Big problem with your #1 there:
If you read the filing it states that they are already diluting and continue to dilute daily over and above the AS count that we currently have.

We have issued or agreed to issue convertible securities which would, if converted, require issuance of 16,363,636 shares of common stock which is more than the current authorized capital stock under our Amended Articles of Incorporation.


From what they are saying; There will be no delay in dilution.
Thus, your statement that
Increase of A/S will not be immidiately be in effect and thus we I don't think more dilution will be coming in a near future.
is a bit misplaced, because they state:

Our Board of Directors is currently contemplating initiating a private offering, exempt from registration pursuant to the provisions of Regulation D, with one or a limited number of third-party, accredited investors. It is possible that we will have initiated and/or closed such a potential offering by the time of the Annual Meeting, although such a potential offering may not occur at all. The contemplated private offering (the “Potential New Offering”) may consist of shares of either common stock, convertible preferred stock (“Convertible Preferred Stock”), convertible debt (“Convertible Debt”), and/or warrants to purchase common stock, aggregating up to 15,000,000 shares of common stock, to a limited number of third-party, accredited investors (the “New Investors”), and a number of common stock purchase warrants (the “New Investor Warrants”) that would entitle the holders to purchase additional shares of our common stock. If initiated, the Potential New Offering will be made on terms deemed acceptable by our Board of Directors, which may include a Convertible Preferred Stock or Convertible Debt conversion price per share and a New Investor Warrant exercise price at below the greater of a share of our common stock’s book value or its market value at the time of issuance.